Tortoise Investment Management’s Carrier Global CARR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-383
Closed -$22.9K 413
2025
Q3
$22.9K Sell
383
-11
-3% -$747 ﹤0.01% 495
2025
Q2
$28.8K Buy
394
+44
+13% +$2.98K ﹤0.01% 459
2025
Q1
$22.2K Hold
350
﹤0.01% 480
2024
Q4
$23.9K Hold
350
﹤0.01% 520
2024
Q3
$28.2K Hold
350
﹤0.01% 509
2024
Q2
$22.1K Hold
350
﹤0.01% 516
2024
Q1
$20.3K Hold
350
﹤0.01% 509
2023
Q4
$20.1K Hold
350
﹤0.01% 478
2023
Q3
$19.3K Hold
350
﹤0.01% 466
2023
Q2
$17.4K Hold
350
﹤0.01% 490
2023
Q1
$16K Hold
350
﹤0.01% 491
2022
Q4
$14.4K Hold
350
﹤0.01% 498
2022
Q3
$12K Hold
350
﹤0.01% 501
2022
Q2
$12K Hold
350
﹤0.01% 493
2022
Q1
$16K Hold
350
﹤0.01% 451
2021
Q4
$19K Hold
350
﹤0.01% 407
2021
Q3
$18K Hold
350
﹤0.01% 394
2021
Q2
$17K Hold
350
﹤0.01% 394
2021
Q1
$15K Buy
350
+100
+40% +$3.89K ﹤0.01% 387
2020
Q4
$9K Hold
250
﹤0.01% 424
2020
Q3
$8K Buy
250
+100
+67% +$2.83K ﹤0.01% 399
2020
Q2
$3K Buy
+150
New +$2.79K ﹤0.01% 441

Other funds holding CARR

Tortoise Investment Management's CARR Position: Q4 2025 in Review

Tortoise Investment Management sold out of Carrier Global (CARR) in Q4 2025, closing a stake of 383 shares — an estimated $22.9K sold.

Tortoise Investment Management first reported a position in CARR in Q2 2020 and held it in 22 quarters. The position peaked at $28.8K in Q2 2025. 1,508 funds tracked by Wall St. Rank hold CARR as of Q4 2025.

  • Tortoise Investment Management reported no remaining Carrier Global position as of Q4 2025 after selling out during the quarter.
  • Tortoise Investment Management sold 383 Carrier Global shares in Q4 2025, an estimated $22.9K.
  • Tortoise Investment Management first reported a position in Carrier Global in Q2 2020 and held it in 22 quarters.
  • Tortoise Investment Management's Carrier Global position peaked at $28.8K in Q2 2025.
  • 1,508 funds tracked by Wall St. Rank held Carrier Global as of Q4 2025.

Based on Tortoise Investment Management's 13F filing for Q4 2025, filed 6 Feb 2026.